Hjem
Neurotargeting

Varselmelding

There has not been added a translated version of this content. You can either try searching or go to the "area" home page to see if you can find the information there
News

Ebselen bonding decreases stability of 14-3-3 proteins

Ebselen, a promising drug candidate against cancer, bipolar disorder and the virus infection Covid-19, covalently bonds to cysteine residues in 14-3-3 adaptor proteins, triggering 14-3-3 destabilization and degradation in cells and intact brain tissue when used in therapeutic concentrations, potentially explaining the behavioral and anti-neoplastic effects of this drug.

molecyl
Foto/ill.:
MOLPHARM-AR-2020-000184

Hovedinnhold